IP
39
-6
UPS
55
-6
SWKS
38
-2
PSX
40
-4
AEP
58
2
HSY
40
2
MDLZ
65
-2
CMS
67
3
HOG
50
6
URI
58
-5
KEY
51
-3
VMC
57
-3
INTC
43
6
C
60
-2
HBI
62
4
HON
47
-12
NTRS
49
-5
GM
58
-2
MPC
52
8
WAT
54
2
IP
39
-6
UPS
55
-6
SWKS
38
-2
PSX
40
-4
AEP
58
2
HSY
40
2
MDLZ
65
-2
CMS
67
3
HOG
50
6
URI
58
-5
KEY
51
-3
VMC
57
-3
INTC
43
6
C
60
-2
HBI
62
4
HON
47
-12
NTRS
49
-5
GM
58
-2
MPC
52
8
WAT
54
2
Financhill
Back

Matas AS Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
31

MAASF
Matas AS

Last Price:
11.20
Seasonality Move:
--
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
31
Matas AS (MAASF) is a Sell

Is Matas AS a Buy, Sell or Hold?

  • The current Matas AS [MAASF] share price is $11.20. The Score for MAASF is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • MAASF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

MAASF Stock Price Chart

What is Matas AS's stock price today?

  • The Matas AS share price today is $11.20
    The current trend is relatively stagnant and MAASF is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

MAASF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Sell
Relative Strength Index (14 RSI): 0 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.2 - 11.2) Sell
Bollinger Bands (100): (11.2 - 11.2) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

MAASF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.2 Sell
20-day SMA: 11.2 Sell
50-day SMA: 11.2 Sell
200-day SMA: 11.2 Sell
8-day EMA: 11.2 Sell
20-day EMA: 11.2 Sell
50-day EMA: 11.2 Sell
200-day EMA: 11.2 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Matas AS Earnings Growth & MAASF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Matas AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):